Oral administration of Porphyromonas gingivalis fimbriae with cholera toxin induces anti-fimbriae serum IgG, IgM, IgA and salivary IgA antibodies.
Nagasawa
T
T
Tokyo Medical and Dental University, Department of Periodontology, Japan.
Aramaki
M
M
Takamatsu
N
N
Koseki
T
T
Kobayashi
H
H
Ishikawa
I
I
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000284:Administration, Oral; D000818:Animals; D000907:Antibodies, Bacterial / Q000096:biosynthesis*; D000915:Antibody Affinity; D000942:Antigens, Bacterial / Q000008:administration & dosage*; D001428:Bacterial Vaccines / Q000008:administration & dosage*; D002772:Cholera Toxin / Q000008:administration & dosage; D004797:Enzyme-Linked Immunosorbent Assay; D010861:Fimbriae, Bacterial / Q000276:immunology; D007071:Immunoglobulin A, Secretory / Q000096:biosynthesis; D007132:Immunoglobulin Isotypes / Q000096:biosynthesis / Q000097:blood; D008297:Male; D051379:Mice; D008807:Mice, Inbred BALB C; D016966:Porphyromonas gingivalis / Q000276:immunology*; D018709:Statistics, Nonparametric; D018074:Vaccines, Conjugate / Q000008:administration & dosage
D000276:Adjuvants, Immunologic; D000907:Antibodies, Bacterial; D000942:Antigens, Bacterial; D001428:Bacterial Vaccines; D007071:Immunoglobulin A, Secretory; D007132:Immunoglobulin Isotypes; D018074:Vaccines, Conjugate; D002772:Cholera Toxin